SavedAdd your journal

Journals / Sağlık Bilimlerinde Değer / 2023 / Cilt: 13 - Sayı: 1

Investigation of Aggravating Risk Factors in COVID-19 Infection

COVID-19 Enfeksiyonunda Ağırlaştırıcı Risk Faktörlerinin Araştırılması

Dilek YEKENKURUL
Nevin INCE
Mustafa YILDIRIM
Mehmet Ali SUNGUR
Elif EŞCAN
Fatih DAVRAN
Hasan Baki ALTINSOY
Betül DÖNMEZ
Guleser AKPİNAR
Pages
46–53
Publication Date
2023-01-20
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moderate-severe pneumonic involvement in computed tomography of thorax (p=0.002) and high fever (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Coronavirus disease-2019 caused an epidemic that started in China about two years ago but affected the whole world.
📊
Key Findings & Data:It was aimed to evaluate patients followed up with coronavirus disease-2019 infection, to determine risk factors and indicators for severe infection.
💡
Conclusion & Impact:Moderate-severe pneumonic involvement in computed tomography of thorax (p=0.002) and high fever (p
🔬Design:Research Article
📍Scope:2019 Verileri
⚙️Variables:Koronavirüs hastalığı 2019 · ağırlaştırıcı faktörler · oksijen satürasyonu

Abstract

Aim: Coronavirus disease-2019 caused an epidemic that started in China about two years ago but affected the whole world. It was aimed to evaluate patients followed up with coronavirus disease-2019 infection, to determine risk factors and indicators for severe infection. Material and Methods: Patients who received treatment as inpatient with coronavirus disease-2019 infection between March 15- June 01 2020 were investigated. Patients were divided into two groups according to their oxygen saturation; patients with oxygen saturation over 90% were group 1, patients with 90% or less were determined as group 2. This two groups were compared in terms of aggravating risk factors. Results: In this study, 90 patients (46 female, 44 male) were included. Moderate-severe pneumonic involvement in computed tomography of thorax (p=0.002) and high fever (p

Özet

Amaç: Koronavirüs hastalığı-2019, yaklaşık iki yıl önce Çin'de başlayan ancak tüm dünyayı etkisi altına alan bir salgına neden olmuştur. Koronavirüs hastalığı-2019 enfeksiyonu ile takip edilen hastaların değerlendirilmesi, ciddi enfeksiyon için risk faktörlerinin ve göstergelerinin belirlenmesi amaçlanmıştır. Gereç ve Yöntemler: Koronavirüs hastalığı-2019 enfeksiyonu ile 15 Mart- 01 Haziran 2020 tarihleri arasında yatarak tedavi gören hastalar araştırıldı. Hastalar oksijen satürasyonlarına göre iki gruba ayrıldı; oksijen satürasyonu % 90'ın üzerinde olan hastalar grup 1, % 90 ve altı olan hastalar grup 2 olarak belirlendi. Bu iki grup ağırlaştırıcı risk faktörleri açısından karşılaştırıldı. Bulgular: Bu çalışmaya 90 hasta (46 kadın, 44 erkek) dahil edildi. Bilgisayarlı toraks tomografisinde orta-şiddetli pnömonik tutulum (p=0,002) ve yüksek ateş (p

🔖

Cite This Article

YEKENKURUL, D., INCE, N., YILDIRIM, M., SUNGUR, M. A., EŞCAN, E., DAVRAN, F., ALTINSOY, H. B., DÖNMEZ, B., AKPİNAR, G. (2023). Investigation of Aggravating Risk Factors in COVID-19 Infection. Sağlık Bilimlerinde Değer, Cilt: 13 - Sayı: 1, 46–53. https://ajindex.com/articles/877981

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Phelan AL, Katz R, Gostin LO. The novel coronavirus originating in Wuhan, China: challenges for global health governance. JAMA. 2020; 323(8): 709-10.
  2. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382: 727-33. Republic of Turkey Ministry of Health Directorate General of Public Health, 2020. COVID-19 (SARS-CoV-2 infection) general information, epidemiology and diagnosis. Scientific Board Study. Avaible from:s URL: https://covid19.saglik.gov.tr/Eklenti/39551/0/covid-19rehberigenelbilgilerepidemiyolojivetanipdf.pdf Accessed January 12, 2021.
  3. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708-20. Komurcuoglu B. Clinical and laboratory findings of COVID-19. Eurasian J Pulmonol. 2020; 22: 16-8.
  4. Mizumoto K, Kagaya K, Chowell G. Early epidemiological assessment of the transmission potential and virulence of coronavirus disease 2019 (COVID-19) in Wuhan City: China. BMC Med. 2020; 15(18): 217. Bilgiç Z, Güner R. COVID-19: Pathogenesis, transmission routes and risk factors. Aktaş F, editor. COVID-19: Pandemic Lessons. 1st Edition. Ankara: Turkey Clinics; 2020. p.14-24.
  5. Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte Ratio as an Independent Risk Factor for Mortality in Hospitalized Patients With COVID-19. J Infect. 2020; 81(1): 6-12.
  6. Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, et al. Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis. Int J of Infect Dis. 2020; 94: 91-5.
  7. Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, et al. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19. Front Mol Biosci. 2020; 7: 157. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of immune response in patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020; 71 (15): 762-8.
  8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-62.
  9. Rod JE, Oviedo-Trespalacios O, Cortes-Ramirez J. A brief-review of the risk factors for COVID-19 severity. Rev Saude Publica. 2020; 54: 60. Zhang JJY, Lee KS, Ang LW, Leo YS, Young BE. Risk factors for s